The extents of metabolic syndrome among Antiretroviral Therapy exposed and ART naïve adult HIV patients in the Gedeo-zone, Southern-Ethiopia: a comparative cross-sectional study

Table 3 Magnitude of metabolic syndrome (%MS), among PLHIVSs, in the Gedeo-zone, southern-Ethiopia, 2017–2019

S.no	Factors	n	Elevated Magnitude of metabolic syndrome(%MS^a)		P-value
S.no	Factors	n	%(95% CI)^b	OR(95%CI)^c
1	ART status	633
	ART naïve	211	40.8 (35.5–46.0)	1
	ART exposed	422	43.4 (39.1–47.4)	1.3 (0.9–1.9)	.247
2	Age groups in years	633
	</= 34	315	24.4 (19.4–28.9)	1
	35–44	203	54.7 (48.3–61.1)	4.6 (3.0–7.1)	< 0.001
	>/= 45	115	70.4 (61.7–78.3)	8.4 (5.0–14.2)	< 0.001
2	Sex	633
	Men	257	21.8 (16.7–26.8)	1
	Women	376	56.6 (52.1–61.2)	5.24 (3.5–7.8)	.000
3	Residents	633
	Urban	406	46.8 (41.9–51.5)	1
	Rural	227	34.8 (28.6–41.4)	0.7 (0.5–1.0)	.078
	Total	633	42.5 (39.2–45.7)

a-%MS: Magnitude of Metabolic syndrome b-%(95% CI): Proportion and its 95% confidence intervals. c-OR (95%CI): Odd ratio and 95% confidence intervals

ISSN: 2049-3258